RBC Life Sciences®
February 25, 2009
RBC Life Sciences 2008 Net Sales Increase 13 Percent as its Nutritional Supplements and Medical
Products Brands See Continued Growth
Irving, Texas (RBC Life Sciences: OTCBB: RBCL) RBC Life Sciences, Inc., a provider of
proprietary nutritional supplements, wound care and pain management products, announced today that
2008 net sales increased 13 percent year over year as the company continued its domestic and
The company reported net sales of $30.4 million for the year ended December 31, 2008, compared to
$27 million during the same period last year. It also reported net earnings of $1.62 million, or
$0.07 per diluted share, in 2008 compared to net earnings of $1.69 million, or $0.08 per diluted
share, in 2007.
In 2008, RBC Life Sciences continued the surge in growth that the company witnessed in 2007, when
the firm produced record-setting earnings, said President and CEO John W. Price. Sales generated
by our international licensees grew 18 percent year over year while sales generated by our medical
products brand, MPM Medical, Inc, grew 41 percent during that time. This growth is occurring at the
same time that we are beginning to see good gains in our domestic, independent sales force.
Mr. Price, who was promoted to CEO last month, began laying the framework in early 2008 for
increased domestic and international growth across the companys nutritional supplements and
medical products brands. In addition to hiring a sales director, communications director, science
and technology director and a new vice president of marketing, Mr. Price recruited a
strategic-growth veteran to the board of directors.
With international sales running strongly, Mr. Price redoubled the companys focus on rebuilding
the independent Associate base responsible for driving domestic sales of nutritional supplements.
Since launching the first phase of this effort on November 1, more than 1,000 new Associates have
joined RBC Life Sciences. The second phase of the rebuilding effort will include revising the
Associate compensation system to make it one of the industrys most-rewarding payout plans.
Mr. Price said that 2008 net earnings were affected by improvements to RBC Life Sciences
headquarters facility and upgrades to its operational infrastructure.